Debbie Lawes

Why Canada needs a national vaccine strategy

Debbie Lawes
May 26, 2020

The private sector has little appetite for manufacturing small-volume, niche vaccines for pandemic viruses. That’s why any primary manufacturing facility for vaccines like COVID-19 need to be federally owned and operated.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations:
GlaxoSmithKline, Health Canada, Life Sciences BC, Merck, Novateur Ventures, Pfizer, Sanofi, Vaccine Research Institute, and Vaccines Manufacturing and Innovation Centre
People:
Ali Ardakani
Topics:
COVID-19, national vaccine strategy, and vaccine manufacturing

Other News

A long-term research and pandemic strategy is long overdue

Canada's next industrial strategy needs to focus on business innovation

Thousands of research staff layoffs averted with $450 million wage subsidy

The Short Report – May 20, 2020: Last network renewals for sunsetting NCE program; New accelerator targets healthy living; Canadian health research at “elevated risk” for hacking; and more






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.